Skip to main content
UKPMC Funders Author Manuscripts logoLink to UKPMC Funders Author Manuscripts
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Eur J Epidemiol. 2019 Sep 28;35(10):975–986. doi: 10.1007/s10654-019-00559-6

Healthy lifestyle and the risk of pancreatic cancer in the EPIC study

Sabine Naudin 1, Vivian Viallon 1, Dana Hashim 2, Heinz Freisling 1, Mazda Jenab 3, Elisabete Weiderpass 4,5,6,7, Flavie Perrier 1, Fiona McKenzie 8, H Bas Bueno-de-Mesquita 9,10,11, Anja Olsen 12, Anne Tjønneland 12,13, Christina C Dahm 14, Kim Overvad 14,15, Francesca Romana Mancini 16,17, Vinciane Rebours 18,19, Marie-Christine Boutron-Ruault 16,17, Verena Katzke 20, Rudolf Kaaks 20, Manuela Bergmann 21, Heiner Boeing 21, Eleni Peppa 22, Anna Karakatsani 22,23, Antonia Trichopoulou 22,24, Valeria Maria Pala 25, Giovana Masala 26, Salvatore Panico 27, Rosario Tumino 28, Carlotta Sacerdote 29, Anne M May 30, Carla H van Gils 30, Charlotta Rylander 31, Kristin Benjaminsen Borch 31, María Dolores Chirlaque López 32,33, Maria-Jose Sánchez 33,34, Eva Ardanaz 33,35,36, J Ramón Quirós 37, Pilar Amiano Exezarreta 33,38, Malin Sund 39, Isabel Drake 40, Sara Regnér 40, Ruth C Travis 41, Nick Wareham 42, Dagfinn Aune 11,43,44, Elio Riboli 11, Marc J Gunter 3, Eric J Duell 45, Paul Brennan 46, Pietro Ferrari 1,*
PMCID: PMC7116136  EMSID: EMS86626  PMID: 31564045

Abstract

Background

Pancreatic cancer (PC) is a highly fatal cancer with currently limited opportunities for early detection and effective treatment. Modifiable factors may offer pathways for primary prevention. In this study, the association between the healthy lifestyle index (HLI) and PC risk was examined.

Methods

Within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, 1,113 incident PC (57% women) were diagnosed from 400,577 cancer-free participants followed-up for 15 years (median). HLI scores combined smoking, alcohol intake, dietary exposure, physical activity and, in turn, overall and central adiposity using BMI (HLIBMI) and waist-to-hip ratio (WHR, HLIWHR), respectively. High values of HLI indicate adherence to healthy behaviors. Cox proportional hazard models with age as primary time variable were used to estimate PC hazard ratios (HR) and 95% confidence intervals (CI). Sensitivity analyses were performed by excluding, in turn, each factor from the HLI score. Population attributable fractions (PAF) were estimated assuming participants’ shift to healthier lifestyles.

Results

The HRs for a one-standard deviation increment of HLIBMI and HLIWHR were 0.84 (95% CI: 0.79, 0.89; ptrend=4.3e-09) and 0.77 (0.72, 0.82; ptrend=1.7e-15), respectively. Exclusions of smoking from HLIWHR resulted in HRs of 0.88 (0.82, 0.94; ptrend=4.9e-04). The overall PAF estimate was 19% (95% CI: 11%, 26%), and 14% (6%, 21%) when smoking was removed from the score.

Conclusion

Adherence to a healthy lifestyle was inversely associated with PC risk, beyond the beneficial role of smoking avoidance. Public health measures targeting compliance with healthy lifestyles may have an impact on PC incidence.

Keywords: Pancreatic cancer, healthy lifestyle index, population attributable fraction, EPIC, prospective study

Introduction

In the last decades, the rise in pancreatic cancer (PC) incidence has become a major public health concern with mortality rates expected to double by 2030 in American and European populations [13]. Commonly diagnosed at late stages, PC is a highly fatal cancer with similar incidence and mortality rates [4]. In the current absence of available screening tools [5], the identification of modifiable risk factors might be important for PC prevention.

The World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) international expert panel estimated that at least one-third of all cancers could have been prevented through lifestyle management including diet, obesity and physical activity habits [6]. PC incidence rates are nearly four times higher in high-income countries such as the United States and Western European countries than in middle- and low-income countries [4], suggesting that PC occurrence may be associated with lifestyle factors specifically prevalent in the Western world. Individual examination of lifestyle risk factors of PC have led to the identification of smoking, as well as body fatness, adult attained height, type-2 diabetes, and heavy alcohol drinking as positive risk factors, while diet and physical activity have been inconsistently associated with PC risk [7,8]. There is limited evidence regarding the joint association of different lifestyle factors on PC incidence, especially among European populations [9,10].

Previous epidemiological studies have identified clusters of modifiable exposures, assessable through a priori scores reflecting compliance with primary prevention guidelines [11], which were evaluated in relation to cardiovascular diseases [12,13], cancer incidence [14,15], and overall and cause-specific mortality [16,17]. A multi-component score termed the Healthy Lifestyle Index (HLI), combining information on smoking, alcohol intake, dietary habits, body mass index (BMI), and physical activity has been previously related to colorectal [18], breast [19], gastric [20], and overall cancers [21] within the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Within the American Association of Retired Persons (AARP) study a strong inverse association was observed between the HLI and PC risk[9].

In this work, the association between the HLI and PC risk was examined within the EPIC study. Two versions of the score were used, i.e. (i) with BMI to reflect overall adiposity and (ii) with waist-to-hip ratio to reflect central adiposity. The marginal role of single factors in the HLI score was investigated, particularly smoking. Population attributable fractions were also estimated.

Material and Methods

Study population

EPIC is a multicenter prospective study designed to investigate the etiology of cancer in relation to diet and other lifestyle factors [22]. From 1992 to 2000, 521,324 participants aged from 35 to 70 years were recruited across 10 European countries, mostly from the general population, of which 70% were women. Exceptions were the French cohort (school and university employees), the Spanish and Italian centers (blood donors), Utrecht and Florence centers (breast cancer screening participants), and Oxford (vegetarians and ‘health conscious’ participants). In France, Utrecht and Naples women only were recruited. Study participants provided informed consent before completing questionnaires at baseline. Participants from Norway were excluded from this study, as information on physical activity was not compatible with the other centers [23].

Cancer cases were identified during follow-up based on population cancer registries in Denmark, Italy, Netherlands, Spain, Sweden, and the United Kingdom, and on a combination of methods, including health insurance records, contacts with cancer and pathology registries, and active follow-up of EPIC participants and their next of kin in France, Germany, and Greece. Mortality data were collected from, either the cancer or mortality registries at the regional or national level.

The most recent vital status and cancer diagnosis update were used. Vital status was known for 98.4% of all EPIC subjects, while 1.6% of participants emigrated, withdrew or were lost to follow-up. The current follow-up period ended as follows: December 2009 in Varese and Murcia, December 2010 in Florence, Ragusa, Turin, Asturias, Bilthoven and Utrecht, December 2011 in Granada, Navarra, San Sebastian and Cambridge, December 2012 in Oxford, Umeå, and Denmark, and December 2013 in Malmö. The end of follow-up was considered as the last known contact with participants in France (June 2008), Heidelberg and Potsdam (December 2009), and Naples (December 2010) and Greece (December 2012). Cases of PC were primary incident tumor of the pancreas, coded according to the International Classification of Diseases (10th edition), which included all invasive pancreatic cancers (C25.0–C25.3, C25.7–C25.9). Endocrine and neuroendocrine tumors of the pancreas (C25.4) were censored at date of diagnosis (n=54). Microscopically confirmed PC represented 83% of the cases (n=928) based on histology of the primary tumor or metastases, cytology or autopsy reports.

Exposure assessment

Habitual diet, including alcohol intake, over the year preceding recruitment was assessed at baseline by validated center-specific dietary questionnaires [22,24]. Data on anthropometry (self-reported in France and the UK Oxford center) [25,26] physical activity, smoking habits, and prevalent chronic conditions were collected at recruitment through lifestyle questionnaires [22].

A diet score was built from the combination of six dietary factors reflecting diet quality [21], i.e. cereal fibers, red and processed meat, the ratio of polyunsaturated to saturated fatty acids, margarine (to express industrially produced trans-fats) [27,28], glycemic load, and fruits and vegetables. For each dietary factor, residuals were computed in models with total energy intake [29], and grouped into country-specific deciles. Individual scores were summed up and categorized into quintiles.

The HLI was generated from the combination of five lifestyle factors, namely: diet score, physical activity, smoking status, alcohol consumption and anthropometry. For each factor, scores ranging from 0 to 4 were assigned to increasingly healthier categories, as described in Figure 1. The HLI was obtained as the sum of scores of each lifestyle factor [19]. As previous evidence on PC etiology identified waist-to-hip ratio, an indicator of central adiposity, as a PC risk factor [30,31], a HLI based on WHR (HLIWHR) was implemented replacing BMI with sex-specific WHR quintiles.

Fig 1. Scoring system implemented to combine the 5 lifestyle factors into the Heathy Lifestyle Index based on the waist-to-hip ratio (HLIWHR).

Fig 1

1For the HLIBMI, sex-specific waist-to-hip ratio quintiles was replaced by categories of BMI at baseline using cut-offs as (4) 22–23.9 kg.m-2, (3) 24–25.9kg.m-2, (2) <22 kg.m-2, (1) 26–29.9kg.m-2, and (0) >30 kg.m-2.

Statistical analysis

From a study population of 521,324 participants, subjects without lifestyle or dietary information (n= 6,902), with ratio of estimated energy intake over energy requirement in the top or bottom 1% (n=10,241),[32] with self-reported prevalent cancer (n=24,221), with missing follow-up information (n=3,800), with missing smoking status (n=15,684) or physical activity (n=65,054) were excluded. For analyses with HLIWHR, subjects with missing WHR were also excluded (n=45,105). Country-specific age standardized PC incidence rates (ASR, per 100,000 person-years, PY) were computed using 5-year categories in the range 50 to 70 years and the standard European population.

The association between the HLI and PC incidence was evaluated using multivariable Cox proportional hazard models, with age as the primary time variable, and Breslow’s method to handle ties [33]. The time at study entry was age at recruitment, while the exit time was age at cancer diagnosis, death, loss, or end of follow-up, whichever came first. All models were stratified by study center [32], sex and age at recruitment in 1-year categories.

The HLIBMI and HLIWHR were, in turn, modeled as continuous variables to compute HR estimates for a one-standard deviation (1-SD), corresponding to about three-point increase in the score. Analyses were also carried out in categories (0-4, 5-9, 10-14, 15-20), using the group 5-9 as reference. Models were systematically adjusted for potential risk factors of PC and covariates influencing HLI and PC risk [21,3436], namely education level (no degree/primary school, secondary/technical or professional school, university degree or more, unknown (4%)), self-reported baseline diabetes status (no, yes, unknown (8%)), energy intake from non-alcohol sources (continuous), and height (continuous). Additional adjustment for BMI (continuous) was used in models for HLIWHR. HRs were unchanged after women-specific inclusion of menopausal status, ever use of replacement hormonal replacement therapy and number of full-term pregnancies, thus adjustment for these variables was not pursued. Overall tests for statistical significance of HRs were determined by comparing Wald-test statistics to a χ2 distribution with degree of freedom (dof) equal to the number of categories minus one for evaluation in categories (pWald) and dof equal to one as continuous (ptrend). The proportionality of hazards (PH) assumption was evaluated through the Schoenfeld’s residuals [37].

Sensitivity analyses were carried out by excluding, in turn, each factor from the HLI scores to identify factors mostly driving the HLI association with PC risk. The excluded component was used as a confounder in the model.

Assuming a causal relationship between HLIWHR and PC risk, population attributable fractions (PAF) were estimated as the reduction in PC incidence that would occur if study participants shifted to the adjacent healthier category of HLIWHR, as [38]

PAF=i=1kRRicii=1kRRici*i=1kRRici,

with i=1,…,4 indexing the HLIWHR categories, HRi and ci expressing the hazards ratio and the observed proportion of participants in category i, respectively, and ci* the counterfactual proportion of participants, as detailed in Supplementary Table 1. PAF was also computed assuming a counterfactual scenario whereby men adopted women’s lifestyle habits. Given the low PC prevalence and under the proportional hazards assumption, HRs were correct approximations of risk ratios (RRi). Confidence intervals were obtained using bootstrap sampling [39].

The relationship between the HLI and PC risk was estimated by, in turn, sex, European regions (North: Denmark, Sweden; Central: The United Kingdom, The Netherlands, Germany; South: France, Greece, Italy, and Spain), and smoking status (never, former, current). Interactions were evaluated by comparing the difference in log-likelihood of models with and without interaction terms between HLIWHR and, either sex, European region or smoking, to a χ2 distribution, with dof equal to the total number of interaction terms minus one. Although the PH assumption was satisfied, possible selections could operate among study participants within 15 year of follow-up, and HR estimates can change with age. The pattern of HR for a 1-SD increase of HLIWHR by age was examined using a flexible parametric survival model on the cumulative hazard scale. Restricted cubic splines with 5 internal knots were used to model the baseline hazard using attained age as the time scale and a time-varying coefficient on HLIWHR [40].

To address potential reverse causality, analyses were carried out excluding the first 2 and 5 years of follow-up. In analyses excluding smoking from the HLI, HR estimates after adjustment by smoking status (never, former, current), smoking intensity (number of cigarette/day, continuous) and duration of smoking (years, continuous) were examined. Two-sided p-values were used with a 5% nominal statistical significance. Analyses were performed using Stata 14 [41].

Results

From a total of 400,577 participants (70% women) followed-up for 15 years (median) and a total of 5,544,627 person-years, 1,113 incident PC cases were diagnosed. Exclusion of subjects without information on their WHR led to 1,075 PC cases from a total of 355,472 participants as reported in Table 1. The overall PC ASR was equal to 6.0 per 100,000 person-years, with relatively large and low ASR estimates observed in Germany (9.4 per 100,000 PY) and France (2.1 per 100,000 person-years), respectively. The individual components of the HLI, together with other confounding variables, are described in Table 2. The HLI was inversely related to education, while the prevalence of diabetes at recruitment was stable across HLI categories. The hypothesis of PH assumption was not rejected with p-value equal to 0.24.

Table 1. Country-specific distribution of study participants, PC cases and HLIWHR score in the EPIC cohort.


Participants PC cases FUP1 (years) PY ASR2 Age at baseline1 (years) HLIWHR 1

Denmark 53,570 314 16 (5-18) 794,475 8.5 57 10 (4-15)
France 18,973 16 15 (6-15) 252,504 2.1 53 11 (6-16)
Germany 48,001 115 12 (4-14) 498,390 9.4 51 12 (6-17)
Greece 24,686 41 11 (3-16) 266,330 3.8 53 12 (6-17)
Italy 44,263 103 15 (7-17) 626,927 6.0 51 12 (6-17)
Spain 39,852 105 17 (9-19) 635,724 5.8 49 13 (6-17)
">Sweden 24,038 128 18 (4-22) 394,001 7.4 58 11 (6-16)
NL 30,550 81 15 (6-17) 429,979 5.8 50 13 (7-17)
UK 71,539 172 16 (5-18) 1,069,797 5.2 49 13 (8-18)

All participants 355,472 1,075 15 (5-18) 4,968,127 6.0 52 12 (7-17)

Abbreviations: ASR, age-standardized incidence rate; FUP, follow-up; HLI, healthy lifestyle index; NL: The Netherlands; PC, pancreatic cancer; PY, person-years; UK: United Kingdoms;

1

Median values (5th and 95th percentiles);

2

Country-specific age-standardized incidence rates (per 100,000) were computed using 5-year categories in the age band 50 to 70 years and the standard European population.

Table 2. Baseline characteristics1 of the EPIC participants by categories of the waist-to-hip ratio-based healthy lifestyle index (HLIWHR).


All HLIWHR categories
[0 - 4] [5 - 9] [10 - 14] [15 - 20]

Number of participants (n) 355,472 6,594 79,446 189,732 79,700
Number of PC cases 1,075 45 355 515 160
Person-Years 4,968,127 86,277 1,085,850 2,647,497 1,148,503
Smoking (% never) 45 0 13 48 78
Alcohol (g/day) 7 (0-48) 36 (7-84) 16 (0-53) 6 (0-30) 2 (0-13)
BMI (kg/m2) 25 (20-33) 27 (21-35) 26 (20-34) 25 (20-34) 24 (19-33)
Waist-to-hip ratio 0.83 (0.72, 1.01) 0.98 (0.81-1.08) 0.91 (0.75-1.04) 0.83 (0.71-0.99) 0.77 (0.69-0.92)
Diet score (units) 27 (19-39) 21 (13-29) 24 (15-35) 27 (17-38) 32 (22-41)
Physical activity (MET-hours/week) 74 (19-154) 29 (5-73) 47 (10-129) 78 (23-175) 118 (50-205)
Age at recruitment (years) 52 (39-64) 54 (41-64) 53 (37-66) 53 (34-68) 51 (30-67)
Height (cm) 165 (152-182) 171 (157-184) 168 (154-183) 165 (152-182) 164 (151-181)
Weight (kg) 68 (51-95) 80 (58-106) 75 (54-101) 70 (52-95) 66 (51-88)
Diabetes (%) 3 3 3 3 3
Education (% below secondary) 31 45 37 33 30
Energy from non-alcohol drinking (kcal/day) 1,959 (1,337-2,814) 2,304 (1,430-3,675) 2,158 (1,311-3,433) 2,011 (1,229-3,209) 1,966 (1,211-3,095)

1

Medians (5th - 95th percentiles) are presented for continuous variables, percentages for categorical variables.

A 1-SD higher HLI was inversely associated with PC risk, with HR equal to 0.84 (95%CI: 0.79, 0.89, ptrend=4.3e-09) for HLIBMI and 0.77 (0.72, 0.82, ptrend=1.7e-15) for HLIWHR, as shown in Table 3. These patterns were confirmed for PC HR estimates for analyses in categories, consistently for HLIBMI and HLIWHR.

Table 3. Hazard Ratio estimates for associations between the combined HLIBMI and HLIWHR and PC risk in the EPIC study.


HLIBMI 2
HLIWHR 3
Cases PY HR (95%CI) p-value4 Cases PY HR (95%CI) p-value4

HLI Categories

[0 - 4] 33 78,738 1.49 (1.03 - 2.13) 45 86,277 1.45 (1.06 - 1.99)
[5 - 9] 338 1,271,983 1.00 Ref. 355 1,085,850 1.00 Ref.
[10 - 14] 570 3,061,318 0.75 (0.65 - 0.87) 515 2,647,497 0.65 (0.57 - 0.75)
[15 - 20] 172 1,132,588 0.64 (0.52 - 0.78) 3.0e-07 160 1,148,503 0.55 (0.45 - 0.68) 6.2e-13

1-SD increase1

1,113 5,544,627 0.84 (0.79 - 0.89) 4.3e-09 1,075 4,968,127 0.77 (0.72 - 0.82) 1.7e-15

1

One standard deviation corresponded to about 3 units of either HLIBMI or HLIWHR;

2

Models were adjusted for education level, diabetes status, and non-alcohol energy intakes, height, and stratified by study center, age in 1-year category, and sex;

3

Models were adjusted for education level, diabetes status, non-alcohol energy intakes, height, BMI and stratified by study center, age in 1-year category, and sex;

4

For categorical variables, p-values were determined using a Wald test for overall significance, according to a χ2 distribution with degrees of freedom equal to the number of categories minus one.

Results of sensitivity analyses are displayed in Figure 2. After exclusion of smoking status, the HR for a 1-SD increase of HLIBMI was 0.94 (95%CI: 0.88, 1.01; ptrend=0.11), and after exclusions of, in turn, alcohol and BMI, HRs were 0.85 (0.80, 0.91; ptrend=6.3e-07) and 0.79 (0.74, 0.85; ptrend=7.6e-12), respectively. After exclusion of, in turn, smoking, alcohol, waist-to-hip ratio from the HLIWHR score, HRs were equal to 0.88 (0.82, 0.94; ptrend=4.9e-04), 0.79 (0.74, 0.84; ptrend=7.0e-13) and 0.79 (0.74, 0.85; ptrend=3.2e-11), respectively.

Fig 2. Hazard ratio estimates for the associations between a 1-SD increment of HLI1 and PC risk after recalculation of the HLIBMI and the HLIWHR excluding, in turn, each lifestyle factor.

Fig 2

1 One Standard deviation corresponded to about 3 units of either HLIBMI or HLIWHR;

2 Models evaluating associations between the HLIBMI and PC risk were adjusted for education level, diabetes status, non-alcohol energy intakes, height, and the index components currently excluded from the calculation of the HLI, and stratified by study center, age and sex;

3 Models evaluating associations between the HLIWHR and PC risk were adjusted for education level, diabetes status, non-alcohol energy intakes, height, BMI and the index components currently excluded from the calculation of the HLI, and stratified by study center, age and sex.

PAF estimates for a shift of participants to the adjacent healthier category of HLIWHR was equal to 19% (95%CI: 11%, 26%) (Table 4). Excluding, in turn, smoking, alcohol and WHR from the HLIWHR showed PAF estimates of 14% (6%, 21%), 19% (10%, 25%), and 16% (9%, 22%), respectively. PAF were 8% (-3%, 18%) for non-smokers at baseline (never and former) and 20% (7%, 35%) for current smokers. PAF estimates were 29% (16%, 37%) in men, and 13% (2%, 24%) in women. Counterfactual scenario whereby men adopted women’s lifestyle habits showed a PAF of 13% (9%, 26%).

Table 4. Population attributable fractions (PAF) of PC assuming counterfactual scenarios with the HLIWHR in the EPIC study.


PAF (%) (95%CI)

Shift to the adjacent healthier category of HLIWHR
All participants 19% (11%, 26%)
without Smoking 14% (6%, 21%)
without Alcohol 19% (10%, 25%)
without WHR 16% (9%, 22%)
without Diet 21% (15%, 26%)
without Physical activity 17% (9%, 23%)
Non-smokers 8% (-3%, 18%)
Smokers 20% (7%, 35%)
Men 29% (16%, 37%)
WomenShift of lifestyle habits2 13% (2%, 24%)
Men to Women 13% (9%, 16%)

1

Confidence intervals were obtained using a bootstrap sampling procedure using 1,000 iterations;

2

The counterfactual proportions of men across HLIWHR categories were equal to the observed proportions of women in each HLIWHR categories.

The association between the HLIWHR and PC risk were similar by sex, European region, and smoking status with pheterogeneity equal to 0.35, 0.15 and 0.62, respectively (Figure 3). Although the PH assumption was satisfied, PC HR estimates for HLIWHR showed weaker associations at older ages (Figure 4). Exclusion of the first 2 and 5 years of follow-up did not materially alter HRs. After exclusion of smoking from the HLI and adjustment by smoking status, intensity and duration, HRs were unchanged (not shown).

Fig 3. Heterogeneity in the relationship between HLIWHR and PC by sex, European region, and smoking status, expressed for a 1-SD increase of HLIWHR1.

Fig 3

1 One Standard deviation corresponded to about 3 units of either HLIBMI or HLIWHR;

2 Northern Europe included Denmark and Sweden, Central Europe included United Kingdom, The Netherlands and Germany, and Southern Europe included France, Greece, Italy and Spain;

3 Models were computed using the HLIWHR excluding smoking;

4 Models included interaction terms between HLIWHR and, in turn, sex, European region, and smoking status at recruitment. Differences in HRs were assessed comparing the log-likelihood of models with and without interaction terms to a χ2 distribution with degrees of freedom equal to the number of categories minus one.

Fig 4. Hazard ratio function (and 95%CI)1 for the association between HLIWHR and PC risk over years of age, for 1-SD increase of HLIWHR .

Fig 4

1 Obtained from a flexible parametric survival model using restricted cubic splines with 5 internal knots and a time-varying coefficient on HLIWHR. Model was adjusted for educational level, BMI, height, non-alcohol energy intake, diabetes status, sex, country, age at recruitment.

Discussion

In this large European prospective study, healthy lifestyle habits expressed as a HLI score were strongly inversely related to the risk of PC. Adherence to healthy behaviors corresponding to a three-point increase in the score was associated with a 16% (95%CI: 11%, 21%) lower PC risk for a score that included BMI, and 23% (18%, 28%) lower PC risk for a score based on WHR. These results support the adoption of healthy lifestyles in PC prevention.

Scores reflecting dietary and lifestyle habits have become increasingly popular in cancer epidemiology research [21,42,43]. In EPIC, scores expressing adherence to either the Mediterranean diet or the WCRF/AICR recommendations have mainly focused on diet, physical activity and anthropometry, and had previously shown null associations with PC risk in both men and women [44,45]. Within the NIH-AARP study, a score based on the American Cancer Society recommendations including physical activity, diet, BMI, alcohol, but not smoking, was associated with a 20% (95%CI: 3%, 35%) lower PC risk in men, comparing the top vs. bottom category, while no association was observed in women [46]. Within the same cohort, an inverse association was observed between HLI and PC, when smoking was added to the score [9].

In the current study, a comprehensive evaluation of the association between HLI and PC risk was undertaken using sensitivity analyses. As smoking is an established strong risk factor of PC [47], it has been suggested that the association between lifestyle habits and PC might be primarily driven by smoking [45]. In our analysis, HLI was inversely associated with PC risk even after excluding smoking from the score, with a 12% risk reduction associated with a three-point (1-SD) increase in the HLIWHR (95%CI: 6%, 18%; ptrend=4.9e-04). Additionally, in never and former smokers, the PC HR for a three-point increase in the HLI was equal to 0.87 (0.79, 0.95; ptrend=2.0e-03, data not shown), suggesting the advantage of adopting healthy habits for PC prevention, beyond the benefit of smoking avoidance.

Body fatness is also an established risk factor for PC [8,48]. A recent pooled analysis concluded that central adiposity during adulthood assessed through waist circumference, or waist-to-hip ratio may also predict PC risk independently from BMI [49]. In our study, HLI based on WHR showed a marginally stronger relationship with PC risk than HLI based on BMI. The subcutaneous truncal adipose tissue has been positively associated with the development of insulin resistance and diabetes [31,50,51], two recognized risk factors for PC [52], and may explain the role of central adiposity, rather than overall adiposity, in PC etiology. Moreover, smoking and alcohol consumption have been previously associated with increasing visceral fat deposition [53,54], which may suggest common pathways between smoking, alcohol consumption and central adiposity in pancreas carcinogenesis.

In our study, the association between HLI and PC was marginally stronger at younger ages compared to older ages. This pattern could be due to a depletion overtime of participants susceptible to PC [55], a phenomenon resulting in an over representation of non-susceptible participants with adverse lifestyle profiles at older ages, thus leading to weaker relationships. Alternatively, HR patterns could be ascribed to study participants’ changes towards healthier lifestyle habits related to ageing, or ultimately due to a true causal association indicating that PC benefits could be more substantial if favorable lifestyle habits were adopted at younger ages [56].

This study is to date the first evaluation of the association between a combination of healthy lifestyle factors and PC incidence in European populations, thus corroborating previous evidence from a US study [9]. The strengths of the present study rely on its prospective multi-country design reflecting heterogeneous lifestyle habits. Its large sample size and long follow-up time allowed ascertainment of over a thousand incident PC cases, increasing the statistical power in comparison with the previous EPIC evaluation [44]. Furthermore, associations were unchanged after exclusion of the first years of follow-up. However, this study also has limitations. First, measurement errors likely affected dietary and lifestyle assessments, possibly introducing bias in estimated associations. Furthermore, as EPIC participants represent a healthy proportion of the general population, risk estimates in our study were likely attenuated. In addition, the evidence for a role of life course socio-economic status on cancer-related risk factors was suggested [57], and the use of education in our study as a proxy for socio-economic status might have introduced residual confounding. Last, our study did not consider potential changes in dietary and lifestyle exposures after recruitment, which could be relevant to estimate the association between lifestyle factors and PC risk, as well as to explain HR patterns over age.

Assuming that HLI was causally related to PC risk, and that combinations of different lifestyle factors leading to the same value of the HLI had the same effect on PC risk, PAF estimates indicated that 14% (95%CI: 6%, 21%) of PC could have been avoided by controlling central adiposity, alcohol consumption, diet and physical activity, and up to 19% (11%, 26%) if smoking control was also implemented, indicating the benefit of adopting healthy lifestyle beyond smoking control. In the AARP study, the PAF was 27% assuming that participants adopted the healthiest lifestyle pattern [9], while in a recent Australian PC study considering only smoking and BMI, the PAF was 30% [58].

Conclusion

In conclusion, our findings provide evidence that adherence to a combination of healthy lifestyle habits was strongly inversely associated with PC risk in European adults. Inverse associations were observed even after dismissing, in turn, smoking, alcohol drinking, and adiposity. Adherence to healthy lifestyle habits, especially from younger ages, could be an effective primary prevention strategy to control the incidence of PC, a fatal cancer with no screening tools currently available for early detection.

Supplementary Material

Supplementary Table 1

Acknowledgments

We thank Carine Biessy and Bertrand Hemon for their technical support and contribution to this work, as well as all the participants of the EPIC cohort.

Abbreviations

BMI

Body Mass Index

CI

Confidence Interval

EPIC

European Prospective Investigation into Cancer and Nutrition

HR

Hazard Ratio

PC

Pancreatic Cancer

PAF

Population Attributable Fraction

WCRF/AICR

World Cancer Research Fund/American Institute for Cancer Research

WHR

Waist-to-Hip ratio

Footnotes

Financial disclosure

This work was supported by the Direction Générale de la Santé (French Ministry of Health) (Grant GR-IARC-2003-09-12-01), by the European Commission (Directorate General for Health and Consumer Affairs) and the International Agency for Research on Cancer. The national cohorts are supported by the Danish Cancer Society (Denmark); the Ligue Contre le Cancer, the Institut Gustave Roussy, the Mutuelle Générale de l’Education Nationale and the Institut National de la Santé et de la Recherche Médicale (France); the Deutsche Krebshilfe, the Deutsches Krebsforschungszentrum, and the Federal Ministry of Education and Research (Germany); the Hellenic Health Foundation, the Stavros Niarchos Foundation and the Hellenic Ministry of Health and Social Solidarity (Greece); the Italian Association for Research on Cancer and the National Research Council (Italy); the Dutch Ministry of Public Health, Welfare and Sports, the Netherlands Cancer Registry, LK Research Funds, Dutch Prevention Funds, the Dutch Zorg Onderzoek Nederland, the World Cancer Research Fund and Statistics Netherlands (the Netherlands); the Health Research Fund, Regional Governments of Andalucýa, Asturias, Basque Country, Murcia (project 6236) and Navarra, Instituto de Salud Carlos III, Redes de Investigacion Cooperativa (RD06/0020) (Spain); the Swedish Cancer Society, the Swedish Scientific Council and the Regional Government of Skåne (Sweden); Cancer Research UK (14136 to EPIC-Norfolk; C570/A16491 and C8221/A19170 to EPIC-Oxford), Medical Research Council (1000143 to EPIC-Norfolk, MR/M012190/1 to EPIC-Oxford) (United Kingdom), the Stroke Association, the British Heart Foundation, the Department of Health, the Food Standards Agency, and the Wellcome Trust (UK). This work was part of Sabine Naudin’s PhD at Claude Bernard Lyon I University (France), funded by Région Auvergne Rhône-Alpes, ADR 2016 (France).

Conflict of interest

None to declare.

Copyright statements

Where authors are identified as personnel of the International Agency for Research on Cancer / World Health Organization, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy or views of the International Agency for Research on Cancer / World Health Organization.

Data sharing statement

Information to submit an application to have access to EPIC data and/or biospecimens can be found at http://epic.iarc.fr/access/index.ph.

References

  • 1.Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913–21. doi: 10.1158/0008-5472.CAN-14-0155. [DOI] [PubMed] [Google Scholar]
  • 2.Malvezzi M, Bertuccio P, Levi F, La Vecchia C, Negri E. European cancer mortality predictions for the year 2014. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2014;25:1650–6. doi: 10.1093/annonc/mdu138. [DOI] [PubMed] [Google Scholar]
  • 3.Ferlay J, Partensky C, Bray F. More deaths from pancreatic cancer than breast cancer in the EU by 2017. Acta Oncol Stockh Swed. 2016;55:1158–60. doi: 10.1080/0284186X.2016.1197419. [DOI] [PubMed] [Google Scholar]
  • 4.Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi: 10.3322/caac.21492. [DOI] [PubMed] [Google Scholar]
  • 5.Lindquist CM, Miller FH, Hammond NA, Nikolaidis P. Pancreatic cancer screening. Abdom Radiol N Y. 2018;43:264–72. doi: 10.1007/s00261-017-1308-z. [DOI] [PubMed] [Google Scholar]
  • 6.IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Personal habits and indoor combustions. Volume 100 E. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum World Health Organ Int Agency Res Cancer. 2012;100:1–538. [PMC free article] [PubMed] [Google Scholar]
  • 7.Maisonneuve P, Lowenfels AB. Risk factors for pancreatic cancer: a summary review of meta-analytical studies. Int J Epidemiol. 2015;44:186–98. doi: 10.1093/ije/dyu240. [DOI] [PubMed] [Google Scholar]
  • 8.World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Expert Report 2018. Diet, nutrition, physical activity and pancreatic cancer. 2018 www.dietandcancerreport.org. [Google Scholar]
  • 9.Jiao L, Mitrou PN, Reedy J, Graubard BI, Hollenbeck AR, Schatzkin A, et al. A combined healthy lifestyle score and risk of pancreatic cancer in a large cohort study. Arch Intern Med. 2009;169:764–70. doi: 10.1001/archinternmed.2009.46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Lucas AL, Bravi F, Boffetta P, Polesel J, Serraino D, La Vecchia C, et al. Adherence to World Cancer Research Fund/American Institute for Cancer Research recommendations and pancreatic cancer risk. Cancer Epidemiol. 2016;40:15–21. doi: 10.1016/j.canep.2015.10.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Schuit AJ, van Loon AJM, Tijhuis M, Ocké M. Clustering of lifestyle risk factors in a general adult population. Prev Med. 2002;35:219–24. doi: 10.1006/pmed.2002.1064. [DOI] [PubMed] [Google Scholar]
  • 12.Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary Prevention of Coronary Heart Disease in Women through Diet and Lifestyle. N Engl J Med. 2000;343:16–22. doi: 10.1056/NEJM200007063430103. [DOI] [PubMed] [Google Scholar]
  • 13.Kurth T, Moore SC, Gaziano JM, Kase CS, Stampfer MJ, Berger K, et al. Healthy Lifestyle and the Risk of Stroke in Women. Arch Intern Med. 2006;166:1403–9. doi: 10.1001/archinte.166.13.1403. [DOI] [PubMed] [Google Scholar]
  • 14.Catsburg C, Miller AB, Rohan TE. Adherence to cancer prevention guidelines and risk of breast cancer. Int J Cancer. 2014;135:2444–52. doi: 10.1002/ijc.28887. [DOI] [PubMed] [Google Scholar]
  • 15.Arthur R, Kirsh VA, Kreiger N, Rohan T. A healthy lifestyle index and its association with risk of breast, endometrial, and ovarian cancer among Canadian women. Cancer Causes Control. 2018;29:485–93. doi: 10.1007/s10552-018-1032-1. [DOI] [PubMed] [Google Scholar]
  • 16.Inoue-Choi M, Robien K, Lazovich D. Adherence to the WCRF/AICR guidelines for cancer prevention is associated with lower mortality among older female cancer survivors. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2013;22:792–802. doi: 10.1158/1055-9965.EPI-13-0054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.McCullough ML, Patel AV, Kushi LH, Patel R, Willett WC, Doyle C, et al. Following cancer prevention guidelines reduces risk of cancer, cardiovascular disease, and all-cause mortality. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2011;20:1089–97. doi: 10.1158/1055-9965.EPI-10-1173. [DOI] [PubMed] [Google Scholar]
  • 18.Aleksandrova K, Pischon T, Jenab M, Bueno-de-Mesquita HB, Fedirko V, Norat T, et al. Combined impact of healthy lifestyle factors on colorectal cancer: a large European cohort study. BMC Med. 2014;12:168. doi: 10.1186/s12916-014-0168-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.McKenzie F, Ferrari P, Freisling H, Chajès V, Rinaldi S, de Batlle J, et al. Healthy lifestyle and risk of breast cancer among postmenopausal women in the European Prospective Investigation into Cancer and Nutrition cohort study. Int J Cancer. 2015;136:2640–8. doi: 10.1002/ijc.29315. [DOI] [PubMed] [Google Scholar]
  • 20.Buckland G, Travier N, Huerta Jm, Bueno-de-Mesquita HB, Siersema Pd, Skeie G, et al. Healthy lifestyle index and risk of gastric adenocarcinoma in the EPIC cohort study. Int J Cancer. 2015;137:598–606. doi: 10.1002/ijc.29411. [DOI] [PubMed] [Google Scholar]
  • 21.McKenzie F, Biessy C, Ferrari P, Freisling H, Rinaldi S, Chajès V, et al. Healthy Lifestyle and Risk of Cancer in the European Prospective Investigation Into Cancer and Nutrition Cohort Study. Medicine (Baltimore) 2016;95:e2850. doi: 10.1097/MD.0000000000002850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002;5:1113–24. doi: 10.1079/PHN2002394. [DOI] [PubMed] [Google Scholar]
  • 23.Ekelund U, Ward HA, Norat T, Luan J, May AM, Weiderpass E, et al. Physical activity and all-cause mortality across levels of overall and abdominal adiposity in European men and women: the European Prospective Investigation into Cancer and Nutrition Study (EPIC)123456. Am J Clin Nutr. 2015;101:613–21. doi: 10.3945/ajcn.114.100065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Kaaks R, Slimani N, Riboli E. Pilot phase studies on the accuracy of dietary intake measurements in the EPIC project: overall evaluation of results. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol. 1997;26(Suppl 1):S26–36. doi: 10.1093/ije/26.suppl_1.s26. [DOI] [PubMed] [Google Scholar]
  • 25.Spencer EA, Appleby PN, Davey GK, Key TJ. Validity of self-reported height and weight in 4808 EPIC-Oxford participants. Public Health Nutr. 2002;5:561–5. doi: 10.1079/PHN2001322. [DOI] [PubMed] [Google Scholar]
  • 26.Spencer EA, Roddam AW, Key TJ. Accuracy of self-reported waist and hip measurements in 4492 EPIC-Oxford participants. Public Health Nutr. 2004;7:723–7. doi: 10.1079/phn2004600. [DOI] [PubMed] [Google Scholar]
  • 27.Chajès V, Biessy C, Byrnes G, Deharveng G, Saadatian-Elahi M, Jenab M, et al. Ecological-level associations between highly processed food intakes and plasma phospholipid elaidic acid concentrations: results from a cross-sectional study within the European prospective investigation into cancer and nutrition (EPIC) Nutr Cancer. 2011;63:1235–50. doi: 10.1080/01635581.2011.617530. [DOI] [PubMed] [Google Scholar]
  • 28.Saadatian-Elahi M, Slimani N, Chajès V, Jenab M, Goudable J, Biessy C, et al. Plasma phospholipid fatty acid profiles and their association with food intakes: results from a cross-sectional study within the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr. 2009;89:331–46. doi: 10.3945/ajcn.2008.26834. [DOI] [PubMed] [Google Scholar]
  • 29.Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr. 1997;65:1220S–1228S. doi: 10.1093/ajcn/65.4.1220S. discussion 1229S-1231S. [DOI] [PubMed] [Google Scholar]
  • 30.Berrington de González A, Spencer EA, Bueno-de-Mesquita HB, Roddam A, Stolzenberg-Solomon R, Halkjaer J, et al. Anthropometry, physical activity, and the risk of pancreatic cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2006;15:879–85. doi: 10.1158/1055-9965.EPI-05-0800. [DOI] [PubMed] [Google Scholar]
  • 31.Janssen I, Heymsfield SB, Allison DB, Kotler DP, Ross R. Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat. Am J Clin Nutr. 2002;75:683–8. doi: 10.1093/ajcn/75.4.683. [DOI] [PubMed] [Google Scholar]
  • 32.Ferrari P, Day NE, Boshuizen HC, Roddam A, Hoffmann K, Thiébaut A, et al. The evaluation of the diet/disease relation in the EPIC study: considerations for the calibration and the disease models. Int J Epidemiol. 2008;37:368–78. doi: 10.1093/ije/dym242. [DOI] [PubMed] [Google Scholar]
  • 33.Thiébaut ACM, Bénichou J. Choice of time-scale in Cox’s model analysis of epidemiologic cohort data: a simulation study. Stat Med. 2004;23:3803–20. doi: 10.1002/sim.2098. [DOI] [PubMed] [Google Scholar]
  • 34.Ferrari P, Jenab M, Norat T, Moskal A, Slimani N, Olsen A, et al. Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC) Int J Cancer. 2007;121:2065–72. doi: 10.1002/ijc.22966. [DOI] [PubMed] [Google Scholar]
  • 35.Ferrari P, Licaj I, Muller DC, Kragh Andersen P, Johansson M, Boeing H, et al. Lifetime alcohol use and overall and cause-specific mortality in the European Prospective Investigation into Cancer and nutrition (EPIC) study. BMJ Open. 2014;4:e005245. doi: 10.1136/bmjopen-2014-005245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Naudin S, Li K, Jaouen T, Assi N, Kyrø C, Tjønneland A, et al. Lifetime and baseline alcohol intakes and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition study. Int J Cancer. 2018;143:801–12. doi: 10.1002/ijc.31367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Schoenfeld D. Partial Residuals for The Proportional Hazards Regression Model. Biometrika. 1982;69:239–41. [Google Scholar]
  • 38.Barendregt JJ, Veerman JL. Categorical versus continuous risk factors and the calculation of potential impact fractions. J Epidemiol Community Health. 2010;64:209–12. doi: 10.1136/jech.2009.090274. [DOI] [PubMed] [Google Scholar]
  • 39.Efron B, Tibshirani R. Bootstrap Methods for Standard Errors, Confidence Intervals, and Other Measures of Statistical Accuracy. Stat Sci. 1986;1:54–75. [Google Scholar]
  • 40.Lambert PC, Royston P. Further Development of Flexible Parametric Models for Survival Analysis. Stata J. 2009;9(2):21. [Google Scholar]
  • 41.StataCorp. Stata Statistical Software: Release 14. College Station, TX: StataCorp LP; 2015. [Google Scholar]
  • 42.Krebs-Smith SM, Pannucci TE, Subar AF, Kirkpatrick SI, Lerman JL, Tooze JA, et al. Update of the Healthy Eating Index: HEI-2015. J Acad Nutr Diet. 2018;118:1591–602. doi: 10.1016/j.jand.2018.05.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Reedy J, Wirfält E, Flood A, Mitrou PN, Krebs-Smith SM, Kipnis V, et al. Comparing 3 Dietary Pattern Methods—Cluster Analysis, Factor Analysis, and Index Analysis—With Colorectal Cancer RiskThe NIH–AARP Diet and Health Study. Am J Epidemiol. 2010;171:479–87. doi: 10.1093/aje/kwp393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Romaguera D, Vergnaud A-C, Peeters PH, van Gils CH, Chan DSM, Ferrari P, et al. Is concordance with World Cancer Research Fund/American Institute for Cancer Research guidelines for cancer prevention related to subsequent risk of cancer? Results from the EPIC study. Am J Clin Nutr. 2012;96:150–63. doi: 10.3945/ajcn.111.031674. [DOI] [PubMed] [Google Scholar]
  • 45.Molina-Montes E, Sánchez M-J, Buckland G, Bueno-de-Mesquita HB, Weiderpass E, Amiano P, et al. Mediterranean diet and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition cohort. Br J Cancer. 2017;116:811–20. doi: 10.1038/bjc.2017.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Kabat GC, Matthews CE, Kamensky V, Hollenbeck AR, Rohan TE. Adherence to cancer prevention guidelines and cancer incidence, cancer mortality, and total mortality: a prospective cohort study. Am J Clin Nutr. 2015;101:558–69. doi: 10.3945/ajcn.114.094854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Lynch SM, Vrieling A, Lubin JH, Kraft P, Mendelsohn JB, Hartge P, et al. Cigarette Smoking and Pancreatic Cancer: A Pooled Analysis From the Pancreatic Cancer Cohort Consortium. Am J Epidemiol. 2009;170:403–13. doi: 10.1093/aje/kwp134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Rawla P, Thandra KC, Sunkara T. Pancreatic cancer and obesity: epidemiology, mechanism, and preventive strategies. Clin J Gastroenterol. 2019;12:285–91. doi: 10.1007/s12328-019-00953-3. [DOI] [PubMed] [Google Scholar]
  • 49.Genkinger JM, Kitahara CM, Bernstein L, Berrington de Gonzalez A, Brotzman M, Elena JW, et al. Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies. Ann Oncol. 2015;26:2257–66. doi: 10.1093/annonc/mdv355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Patel P, Abate N. Body Fat Distribution and Insulin Resistance. Nutrients. 2013;5:2019–27. doi: 10.3390/nu5062019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Taylor R. Insulin Resistance and Type 2 Diabetes. Diabetes. 2012;61:778–9. doi: 10.2337/db12-0073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Song S, Wang B, Zhang X, Hao L, Hu X, Li Z, et al. Long-Term Diabetes Mellitus Is Associated with an Increased Risk of Pancreatic Cancer: A Meta-Analysis. PloS One. 2015;10:e0134321. doi: 10.1371/journal.pone.0134321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Chiolero A, Faeh D, Paccaud F, Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr. 2008;87:801–9. doi: 10.1093/ajcn/87.4.801. [DOI] [PubMed] [Google Scholar]
  • 54.Molenaar EA, Massaro JM, Jacques PF, Pou KM, Ellison RC, Hoffmann U, et al. Association of lifestyle factors with abdominal subcutaneous and visceral adiposity: the Framingham Heart Study., Association of Lifestyle Factors With Abdominal Subcutaneous and Visceral Adiposity: The Framingham Heart Study. Diabetes Care Diabetes Care. 2009;32:505–10. doi: 10.2337/dc08-1382. 32, 505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Hernán MA. The Hazards of Hazard Ratios. Epidemiol Camb Mass. 2010;21:13–5. doi: 10.1097/EDE.0b013e3181c1ea43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.White MC, Holman DM, Boehm JE, Peipins LA, Grossman M, Henley SJ. Age and Cancer Risk. Am J Prev Med. 2014;46:S7–15. doi: 10.1016/j.amepre.2013.10.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Akinyemiju T, Ogunsina K, Okwali M, Sakhuja S, Braithwaite D. Lifecourse Socioeconomic Status and Cancer-Related Risk Factors: Analysis of the WHO study on Global Ageing and Adult Health (SAGE) Int J Cancer. 2017;140:777–87. doi: 10.1002/ijc.30499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Wilson LF, Antonsson A, Green AC, Jordan SJ, Kendall BJ, Nagle CM, et al. How many cancer cases and deaths are potentially preventable? Estimates for Australia in 2013. Int J Cancer. 2018;142:691–701. doi: 10.1002/ijc.31088. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Table 1

RESOURCES